Aurealis Pharma
Series BAurealis Pharma raised €6.9M in a Series B round in Jan 2019. The company is based in Kuopio, Finland. Investors in the round: Finnvera Venture Capital. Data as of Nov 2026.
Amount raised
€6.9M
€6,921,643
Native amount
7,800,000 CHF
Stage
Series B
series b
Investors
1
Provenance & confidence
High confidenceAmount
7,800,000 CHF
ECB-at-date → €6.9M · rate 1.1269 on 2018-12-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
1 namedDate
Jan 2019
Round type
series b
Amount (EUR)
€6.9M
Other rounds
same companyThis is the company's only recorded round.